{first_name}
{last-initial}
{age}
{city}
{country-list}
π Supporting Research & Reports (Citing 2025 Actions)
Medicare Price negotiation rollbacks for Part D drugs Medicaid Work requirements, reduced federal match for states FDA/Drug Policy Fast-tracking drug approvals with less pricing oversight Public Health Cuts to prevention, early detection, and chronic care services Equity Programs DEI and equity-based health initiatives defunded or dismantled π V. Supporting Research ...